Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ian Schofield

Edinburgh, U.K
Ian Schofield has been writing on issues affecting the pharmaceutical and biotech industry since the mid-1980s, specialising in EU and global policy and regulatory affairs.  As well as writing, editing and commissioning articles for Pharma Intelligence, Ian works for the Ask the Analyst service, providing tailor-made answers to questions posed directly by clients. He has a degree in modern languages from the University of Bath. Outside the realm of work, Ian plays guitar in a traditional music group and also enjoys a touch of cycling and gardening. He lives by the seaside about three miles from the centre of Edinburgh.
Advertisement
Set Alert for Articles By Ian Schofield

Latest From Ian Schofield

UK Signs First No-Deal Brexit Ferry Contracts

If the UK leaves the EU without a deal at the end of this month, pharmaceutical companies will be able to book space for medicine deliveries on ferries run by four operators between UK and EU ports. 

Europe United Kingdom

Register Now For No-Deal Brexit Ferry Routes, Says BIA

Life science firms wanting to avoid possible blockages at the Channel ports if the UK leaves the EU without a deal are being advised by the BioIndustry Association to register now. Meanwhile the government has published a report that brings together all its advice on preparing for a no-deal Brexit.

Brexit United Kingdom

Register Now For No-Deal Brexit Ferry Routes Says BIA

Life science firms wanting to avoid possible blockages at the Channel ports if the UK leaves the EU without a deal are being advised by the BioIndustry Association to register now. Meanwhile the government has published a report that brings together all its advice on preparing for a no-deal Brexit.

Brexit United Kingdom

Scotland’s SMC OKs Drugs For Cancer & Plaque Psoriasis

The Scottish Medicines Consortium has OKd Keytruda, Decapeptyl, Yescarta and Skyrizi after patient access schemes were agreed that improved their cost-effectiveness. But Perjeta and Xtandi were rejected because the companies made no solid economic case for NHS funding.

United Kingdom Health Technology Assessment

WHO Steps Up Efforts To Tackle Antimicrobial Resistance

The newly launched 2019 edition of the World Health Organization’s antibiotic database will help countries to monitor and manage antibiotic use as part of the global drive to stem the tide of antimicrobial resistance.

Generic Drugs Infectious Diseases

UK Govt About To Reveal No-Deal Brexit Ferry Routes

The UK government is to write to companies explaining which ferry routes will be open to them when transporting medicines in a no-deal Brexit situation, and how to book space on the ferries. But it's all very last-minute as the Brexit date of 31 October draws near.

United Kingdom Brexit
See All
Advertisement
UsernamePublicRestriction

Register